Curaleaf Holdings has proposed to acquire Aurora Cannabis by offering US$4.00 per share, including cash and Curaleaf shares, representing a 45% premium over Aurora's recent trading price. The deal aims to combine Aurora's EU-GMP cultivation and manufacturing with Curaleaf's processing and distribution, enhancing margins and expanding patient access across multiple countries. Curaleaf urges Aurora's board to engage in discussions, highlighting significant strategic and financial benefits, including cost synergies, expanded market reach, and exposure to the large U.S. cannabis market. The offer is subject to conditions and has not yet been formally commenced.
Aurora Cannabis has received an unsolicited takeover proposal from Curaleaf offering $4 per share, combining cash and Curaleaf shares. Aurora's board is reviewing the offer carefully, noting the price is lower than past trading values and emphasizing...
Curaleaf Holdings has made a hostile bid to acquire Aurora Cannabis, proposing $4 per share through a combination of Curaleaf shares and $0.75 cash per Aurora share. This offer represents a 45% premium over Aurora's recent average price and aims to m...
Aurora Cannabis held its 2026 Annual General Meeting virtually, with 26.86% of shares represented. Shareholders re-elected all nominated directors with over 85% approval and approved Ernst & Young LLP as auditors for the coming year. The advisory vot...
